Taconic Capital Says It Now Owns 7.46% Of Cephalon - Update

Taconic Capital Says It Now Owns 7.46% Of Cephalon - Update

  • Posted Monday, April 18, 2011 -
  • Share |
Taconic Capital Advisors L.P. said Friday it now owns a 7.46 percent stake in biopharmaceutical company Cephalon Inc. (CEPH), which is the target of a $5.7 billion takeover bid by Canadian drugmaker Valeant Pharmaceuticals International Inc. (VRX, VRX.TO).view original article

Related News Items